Phase II Trial of Gemcitabine and ISIS 2503 in Patients With Locally Advanced or Metastatic Pancreatic Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 15 Sep 2005
At a glance
- Drugs Gemcitabine (Primary) ; ISIS 2503 (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 15 Sep 2005 New trial record.